In this study, we present a case of BCR-ABL(+) AML that was treated with a TKI in combination with chemotherapy to induce remission, followed by allogeneic hematopoietic stem cell transplantation (Allo-HSCT). Here, ABL1 is linked to acute myeloid leukemia.